EXOTHERAHead of Development
May. 2020Charleroi, Walloon Region, BelgiumAccountable for the spectra of development activities within a CDMO, ensuring that the Company’s business requirements are properly translated to the development practices and deliverables. Leading development groups of upstream, downstream, analytics, CMC, technology transfer & laboratory support through the pipeline of various biologics process development projects focusing on viral vectors and vector vaccines.